Abstract
An analog of aromatic cytokinins, the 2,6,9-trisubstituted purine derivative bohemine, was applied to cultures of mouse hybridoma cells in order to analyze its capacity of suppressing cell growth and maintaining or enhancing the production of monoclonal antibody. Addition of bohemine at concentrations in the range of1–10 μM resulted in a short-term arrest of growth and of monoclonal antibody production. The short-term suppression of cell functions was followed by a significant temporary increase of specific growth rate and of specific production rate. The steady-state viable cell density values, found in semicontinuous cultures, showed a certain stimulation of cell growth in the range of micromolar concentrations of bohemine, and inhibition of growth at 10 and 30 μM concentrations. The profiles of cell cycle phases indicated that hybridoma cells are retarded both at the G1/S boundary and at the G2/M boundary, depending on bohemine concentration. The existence of the sequence of events,from suppression to stimulation, suggests that bohemine probably modulates more than one regulatory pathway in the cell.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alberio R, Kubelka M, Zakhartchenko V, Hajdúch M, Wolf E & Motlík J (2000) Activation of bovine oocytes by specific inhibition of cyclin-dependent kinases. Mol Reprod Dev 55: 422–432.
Chang Y-T, Gray NS, Rosania GR, Sutherlin DP, Kwon S, Norman TC, Sarohia R, Leost M, Meijer L & Schultz PG (1999) Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors. Chem Biol 6: 361–375
Chmela Z, Veselý J, Lemr K, Rypka M, Hanuš J, Havlíček L, Kryštof V, Michnová L, Fuksová K & Lukeš J (2001) In vivo metabolism of 2,6,9-trisubstituted purine-derived cyclindependent kinase inhibitor bohemine in mice: glucosidation as the principal metabolic route. Drug Metabol Disp vn29: 326–334.
De Azevedo WF, Leclerc S, Meijer L, Havlíček L, Strnad M & Kim SH (1997) Inhibition of cyclin-dependent kinases by purine analogues: Crystal structure of human cdk2 complexed with roscovitine. Eur J Biochem 243: 318–326.
Fenge C, Fraune E, Freitag R, Scheper T & Schügerl K (1991) On-line monitoring of monoclonal antibody formation in highdensity perfusion culture using FIA. Cytotechnology 6: 55–63.
Franěk F, Holý A, Votruba I & Eckschlager T (1998) Modulation of cell cycle progression and of antibody production in mouse hybridomas by a nucleotide analogue. Cytotechnology 28: 65–72.
Frančk F & Šrámková K (1996) Cell suicide in starving hybridoma culture: Survival-signal effect of some amino acids. Cytotechnology 21: 81–89.
Frančk F, Vomastek T & Dolníková J (1992) Fragmented DNA and apoptotic bodies document the programmed way of cell death in hybridoma cultures. Cytotechnology 9: 117–123.
Fussenegger M, Mazur X & Bailey JE (1997) A novel cytostatic process enhances the productivity of Chinese hamster ovary cells. Biotechnol Bioeng 55: 927–939.
Hajdúch M, Havlíček L, Veselý J, Novotný R, Mihál V & Strnad M (1999) Synthetic cyclin-dependent kinase inhibitors. New generation of potent anti-cancer drugs. In: R Pieters, A Veerman and GJL Kaspers (eds) Advances in Experimental Medicine and Biology. Vol. 457 (pp. 341–353), Plenum Press, New York.
Havlíček L, Hanuš J, Veselý J, Leclerc S, Meijer L, Shaw G & Strnad M (1997) Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds. Med Chem 40: 408–412.
Holý A (1994) Isopolar phosphorus-modified nucleotide analogues. In: E DeClercq (ed.), Advances in Antiviral Drug Design (pp. 179–232) JAI Press, Inc., Greenwich, CT.
Kirchhoff S, Kröger A, Cruz H, Tümmler M, Schäper F, Köster M & Hauser H (1996) Regulation of cell growth by IRF-1 in BHK-21 cells. Cytotechnology 22: 147–156.
KováŐová H, Hajdúch M, Kořínková G, Halada P, Krupičková S, Gouldsworthy A, Zhelev N & Strnad M (2000) Proteomics approach in classifying the biochemical basis of the anticancer activity of the new olomoucine-derived synthetic cyclindependent kinase inhibitor, bohemine. Electrophoresis 21: 3757–3764.
Kramata P, Votruba I, Otová B & Holý A (1996) Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases alpha, delta and epsilon. Mol Pharmacol 49: 1005–1011.
Kruh J (1982) Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell Biochem 42: 65–82.
Legraverend M, Ludwig O, Bisagni E, Leclerc S, Meijer L, Giocanti N, Sadri R & Favaudon V (1999) Synthesis and in vitro evaluation of novel 2,6,9-trisubstituted purines acting as cyclindependent kinase inhibitors. Bioorg Med Chem 7: 1281–1293.
Legraverend M, Tunnah P. Noble M, Ducrot P, Ludwig O, Grierson DS, Leost M, Meijer L & Endicott J (2000) Cyclin-dependent kinase inhibition by new C-alkynylated purine derivatives and molecular structure of a CDK2-inhibitor complex. J Med Chem 43: 1282–1292.
Meijer L, Borgne A, Mulner O, Chong JPJ, Blow JJ, Inagaki N, Inagaki M, Delcros J-G & Moulinoux J-P (1997) Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 243: 527–536.
Otyepka M, Kryštof V, Havlíček L, Siglerová V, Strnad M & Koča J (2000) Docking-based development of purine-like inhibitors of cyclin-dependent kinase - 2. J Med Chem 43: 2506–2513.
Pines J (1995) Cyclines and cyclin-dependent kinases: A biochemical view. Biochem J 308: 697–711.
Rosania GR, Chang YT, Perez O, Sutherlin D, Dong H, Lockhart DJ & Schultz PG (2000) Myoseverin, a microtubule-binding molecule with novel cellular effects. Nature Biotechnol 18: 304–308.
Suzuki E & Ollis DF (1990) Enhanced antibody production at slowed growth rates: Experimental demonstration and a structured model. Biotechnol Prog 6: 231–236.
Suzuki E, Takahashi K & Ollis DF (1992) A simple structured model predicted positively-, negatively-, or non-growth associated antibody production rate depending on culture conditions. In: H Murakami et al. (eds.) Animal Cell Technology: Basic and Applied Aspects. Vol. 4 (pp. 375–381), Kluwer Academic Publishers, Dordrecht.
Takahashi K, Terada S, Ueda H, Makishima F & Suzuki E (1994) Growth rate suppression of cultured animal cells enhances protein productivity. Cytotechnology 15: 54–64.
Veselý J, Havlíček L, Strnad M, Blow JJ, Donella-Deana A, Pinna L, Letham DS, Kato J, Detivaud L & Leclerc S (1994) Inhibition of cyclin-dependent kinases by purine analogues. Eur J Biochem 224: 771–786.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Franěk, F., Strnad, M., Havlíček, L. et al. Diverse effects of the cyclin-dependent kinase inhibitor bohemine: Concentration- and time-dependent suppression or stimulation of hybridoma culture. Cytotechnology 36, 117–123 (2001). https://doi.org/10.1023/A:1014020415912
Issue Date:
DOI: https://doi.org/10.1023/A:1014020415912